Frequently Asked Questions About CNTA

What are CNTA's business segments?

Centessa Pharmaceuticals plc (CNTA) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.

Which segment generates the most revenue for CNTA?

Centessa Pharmaceuticals plc's largest reported segment is Reportable Segment, at $15.0 million in revenue for fiscal year 2025 (ended December 31, 2025). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.

How current is CNTA's segment data?

Centessa Pharmaceuticals plc (CNTA)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2025 (ended December 31, 2025). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.

CNTA (Centessa Pharmaceuticals plc) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

CNTA

Centessa Pharmaceuticals plc

NASDAQ·Biotechnology · Healthcare

$40.50$0.00+0.00%

Market cap$6.27B·Market closed·Jun 25 8:00 PM UTC

By Product

Latest period2025

Segment	Revenue	Share	YoY Growth %
Reportable Segment	$15.00M	100.0%	—

Frequently Asked Questions About CNTA

What are CNTA's business segments?: Centessa Pharmaceuticals plc (CNTA) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.
Which segment generates the most revenue for CNTA?: Centessa Pharmaceuticals plc's largest reported segment is Reportable Segment, at $15.0 million in revenue for fiscal year 2025 (ended December 31, 2025). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.
How current is CNTA's segment data?: Centessa Pharmaceuticals plc (CNTA)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2025 (ended December 31, 2025). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.